To homepage
820К+ patients have got assistance since 2014
50 countries
1,500 clinics
6K+ reviews
3K+ qualified doctors

How Much Does Immunotherapy with Keytruda (Pembolizumab) Cost in United Kingdom?

The average price of Immunotherapy with Keytruda (Pembolizumab) in United Kingdom is $32,500, the minimum price is $25,000, and the maximum price is $40,000.
United KingdomTurkeyAustria
Immunotherapy with Keytruda (Pembolizumab)from $25,000from $7,300from $15,000
Data verified by Bookimed as of January 2026, based on patient requests and official quotes from 55 clinics worldwide. Median costs are based on real invoices (2024–2026) and updated monthly. Actual prices may vary.
Authored by Anna Leonova
Head of Content Marketing Team

Your Benefits and Guarantees with Bookimed

Transparent Prices & Flexible Installments

No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible installment plan if needed.

Verified Clinics & Doctors Only

Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.

Free 24/7 Assistance

Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.

Why we?

Your personal Bookimed medical coordinator

  • Supports you at every stage
  • Helps choose the right clinic and doctor
  • Ensures quick and convenient access to information

We're Temporarily Out of Immunotherapy with Keytruda (Pembolizumab) Clinics in United Kingdom — Explore Trusted Options in Turkey and Save Up to 70%.

Procedure type
Keytruda (1 injection, 200 mg)

Turkey, Istanbul

Yesim Yildirim

22 years of experience

The package covers a 200 mg Keytruda injection administered via 30-minute outpatient infusion, minimizing daily disruption. At approximately $4,500, it includes the drug and care from ESMO-certified Prof. Yesim Yildirim, who trained at Rambam Israel and has 80+ research publications. Anadolu Medical Center is JCI-accredited and affiliated with Johns Hopkins. Value-added services like a personal coordinator, interpreter, and a 48-hour medical second opinion are included, while advanced diagnostics like PET-CT are available if needed.

View more

Immunotherapy with Keytruda (Pembolizumab) Overview in United Kingdom

Takeaways
Related procedures & Costs
How it works
What to expect
Benefits
Payment
patients recommend -
85%
Requests processed - 46119
Bookimed fees - $0

Video Stories from Bookimed Patients

Amanda
My companion and I were treated with such kindness — I have nothing but admiration for the entire team.
Procedure: Mastectomy
Randolph
Stay strong, stay informed, and never underestimate the power of cutting-edge treatments and a solid support system.
Procedure: Radioembolization for liver cancer

Share this content

Authored by
Anna Leonova
Anna Leonova
Head of Content Marketing Team
A certified medical writer with 10+ years of experience, developed Bookimed’s trusted content, backed by a Master’s in Philology and medical expert interviews worldwide.
Fahad Mawlood
Medical Editor & Data Scientist
General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Fahad Mawlood Linkedin
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Fast Facts about Immunotherapy with Keytruda (Pembolizumab)

Immunotherapy with Keytruda (Pembolizumab)

Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.

Pros: Offers a targeted approach with fewer side effects; clinical trials show a 70% response rate in some cancers. Suitable for varied cancer types due to its immune modulation properties.
Cons: May cause immune-related adverse effects such as colitis or pneumonitis in up to 10% of patients. Limited effectiveness in tumors with low PD-L1 expression.
Effectiveness: 70% response rate in some cancer types.
Duration: Each session lasts about 30 minutes.
Recovery: Not needed.
Best for: Cancers with high PD-L1 expression, melanoma, and non-small cell lung cancer.
Prices: View costs of other techniques

Get a free consultation

Select the best way to contact you